NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
February 24, 2021
West Pharmaceutical Services, a manufacturer of drug-packaging and delivery components in Kinston for the last four decades, will invest $19 million, add 90 workers over the next year to expand its production capacity there.
February 24, 2021
Morrisville gene editing startup Locus Biosciences has completed the world’s first clinical trial of a recombinant bacteriophage therapy that also marks the first time a CRISPR-enhanced therapeutic has been administered in a clinical setting.
February 24, 2021
, 
North Carolina's Research Triangle, birthplace and global centerpiece of the huge contract research enterprise, is losing a homegrown headquarters with a $12 billion buyout of PRA Health Sciences by Ireland-based ICON plc.
February 23, 2021
Pittsboro-based startup Propella Therapeutics is teaming up with the National Cancer Institute (NCI) to evaluate its new treatment for metastatic prostate cancer.
February 21, 2021
Sam Taylor, a founder and long-time president of the state's life sciences trade association, NCBIO, has died of pancreatic cancer.
February 19, 2021
[Editor's note from Tracey du Laney, Ph.D., the North Carolina Biotechnology Center’s senior director of Science and Technology Development, who oversees this grant: This line of research exemplifies what a Flash Grant is all about. The nanosphere technology that Dr. Brown’s team is developing addresses a large patient population with unmet needs in a new way. It could lead to new therapeutics to treat disseminated intravascular coagulation (DIC). DIC results not just from sepsis and cancer, but also has emerged as a life-threatening condition with COVID-19.
February 19, 2021
Advanced Chemotherapy Technologies, a Raleigh medical device startup developing a way to improve the treatment of pancreatic cancer, has added $2.5 million in funding to support clinical testing of its technology.
February 17, 2021
Durham-based regenerative medicine company Humacyte is going public in a novel deal that will give it a market capitalization of $1.1 billion.
February 15, 2021
A drug being developed by Cary-based Rescindo Therapeutics for treating a rare developmental disorder in children has received two special designations from the FDA.
February 15, 2021
Life sciences manufacturing companies in North Carolina expanded their collective workforce by more than 11%.in 2020, in sharp contrast to the global economic downturn wrought by the COVID-19 pandemic.
February 15, 2021
RTP's G1 Therapeutics has received FDA approval of its first drug, for protecting bone marrow from chemotherapy damage.
February 12, 2021
Veteran pharmaceutical company executive Machelle Sanders, a North Carolina native and former board member of the North Carolina Biotechnology Center, was named Secretary of the Department of Commerce today by Governor Roy Cooper.
February 12, 2021
NC IDEA is welcoming entrepreneurs statewide to submit MICRO and SEED Grant applications until March 1.
February 11, 2021
Medical device maker Bioventus is the latest North Carolina life sciences firm joining the public markets, raising $104 million from its initial public offering.
February 10, 2021
A $1.5 million gift from the North Carolina GlaxoSmithKline Foundation will help community college students pursue science, technology, engineering and math (STEM) degrees at North Carolina Agricultural and Technical State University in Greensboro.